FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024315099> ?p ?o ?g. }

• W2024315099 endingPage "282" @default.
• W2024315099 startingPage "275" @default.
• W2024315099 abstract "<b><i>Background:</i></b> Diabetic retinopathy and diabetic macular oedema are more prevalent in patients with coexistent obstructive sleep apnoea (OSA). <b><i>Objectives:</i></b> We assessed if treatment of OSA with continuous positive airway pressure (CPAP) might improve visual acuity (VA). <b><i>Methods:</i></b> A total of 35 patients with clinically significant macular oedema (CSMO) and OSA [oxygen desaturation index (ODI) ≥10 or apnoea-hypopnoea index (AHI) ≥15] were identified and agreed to be studied. VA (expressed as the logarithm of the minimum angle of resolution, logMAR), macular thickness, fundal photographs, glycosylated haemoglobin (HbA1c) and rhodopsin mRNA were measured twice at baseline and at 3 and 6 months post-CPAP. Fluorescein angiography and the Epworth Sleepiness Scale (ESS) were obtained once at baseline and at 6 months. <b><i>Results:</i></b> Three patients withdrew before the first trial visit. Thus, a total of 32 patients (17 males) entered the study, and 4 subsequently withdrew; thus 28 completed 6 months of follow-up. Baseline characteristics of the subjects were as follows [mean (SD or inter-quartile range)]: age 66.2 (7.1) years, body mass index 31.7 (6.3), HbA1c 7.4% (1.44) [57.1 (15.7) mmol/mol], AHI 16.5 (11–25), ODI 16.0 (12–25), ESS 6.5 (4.0–12.0) and duration of diabetes 9.5 years (5.0–16.5). Participants were divided into 13 high and 15 low CPAP compliers (≥ and <2.5 h/night over the 6 months, respectively). At 6 months, the adjusted treatment effect on VA of high compliance versus low compliance was 0.11 (95% confidence interval 0.21 to –0.002; p = 0.047), equivalent to a one-line improvement on the logMAR chart. There was no significant improvement in macular oedema or fundal photographs. <b><i>Conclusions:</i></b> This hypothesis-generating, uncontrolled study suggests that ≥2.5 h/night CPAP usage over 6 months in individuals with CSMO and OSA may be associated with improvement in VA. This provides justification for a randomised controlled trial of CPAP therapy in such patients." @default.
• W2024315099 created "2016-06-24" @default.
• W2024315099 creator A5009937243 @default.
• W2024315099 creator A5010247381 @default.
• W2024315099 creator A5013551738 @default.
• W2024315099 creator A5018887395 @default.
• W2024315099 creator A5023325590 @default.
• W2024315099 creator A5040561505 @default.
• W2024315099 creator A5050081586 @default.
• W2024315099 creator A5058422290 @default.
• W2024315099 creator A5059272486 @default.
• W2024315099 creator A5059497208 @default.
• W2024315099 creator A5081578787 @default.
• W2024315099 creator A5088847988 @default.
• W2024315099 date "2011-12-20" @default.
• W2024315099 modified "2023-10-07" @default.
• W2024315099 title "Visual Improvement following Continuous Positive Airway Pressure Therapy in Diabetic Subjects with Clinically Significant Macular Oedema and Obstructive Sleep Apnoea: Proof of Principle Study" @default.
• W2024315099 cites W1538100349 @default.
• W2024315099 cites W1574902248 @default.
• W2024315099 cites W1976670525 @default.
• W2024315099 cites W1995951332 @default.
• W2024315099 cites W2009215781 @default.
• W2024315099 cites W2022886290 @default.
• W2024315099 cites W2039248126 @default.
• W2024315099 cites W2044790794 @default.
• W2024315099 cites W2045223197 @default.
• W2024315099 cites W2063135200 @default.
• W2024315099 cites W2095558741 @default.
• W2024315099 cites W2104251791 @default.
• W2024315099 cites W2114942155 @default.
• W2024315099 cites W2116590919 @default.
• W2024315099 cites W2123123877 @default.
• W2024315099 cites W2128196669 @default.
• W2024315099 cites W2128973036 @default.
• W2024315099 cites W2134126089 @default.
• W2024315099 cites W2147810118 @default.
• W2024315099 cites W2161588304 @default.
• W2024315099 cites W2170402055 @default.
• W2024315099 cites W4233235818 @default.
• W2024315099 doi "https://doi.org/10.1159/000334090" @default.
• W2024315099 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22189259" @default.
• W2024315099 hasPublicationYear "2011" @default.
• W2024315099 type Work @default.
• W2024315099 sameAs 2024315099 @default.
• W2024315099 citedByCount "37" @default.
• W2024315099 countsByYear W20243150992013 @default.
• W2024315099 countsByYear W20243150992014 @default.
• W2024315099 countsByYear W20243150992015 @default.
• W2024315099 countsByYear W20243150992016 @default.
• W2024315099 countsByYear W20243150992017 @default.
• W2024315099 countsByYear W20243150992018 @default.
• W2024315099 countsByYear W20243150992019 @default.
• W2024315099 countsByYear W20243150992020 @default.
• W2024315099 countsByYear W20243150992021 @default.
• W2024315099 countsByYear W20243150992022 @default.
• W2024315099 countsByYear W20243150992023 @default.
• W2024315099 crossrefType "journal-article" @default.
• W2024315099 hasAuthorship W2024315099A5009937243 @default.
• W2024315099 hasAuthorship W2024315099A5010247381 @default.
• W2024315099 hasAuthorship W2024315099A5013551738 @default.
• W2024315099 hasAuthorship W2024315099A5018887395 @default.
• W2024315099 hasAuthorship W2024315099A5023325590 @default.
• W2024315099 hasAuthorship W2024315099A5040561505 @default.
• W2024315099 hasAuthorship W2024315099A5050081586 @default.
• W2024315099 hasAuthorship W2024315099A5058422290 @default.
• W2024315099 hasAuthorship W2024315099A5059272486 @default.
• W2024315099 hasAuthorship W2024315099A5059497208 @default.
• W2024315099 hasAuthorship W2024315099A5081578787 @default.
• W2024315099 hasAuthorship W2024315099A5088847988 @default.
• W2024315099 hasBestOaLocation W20243150991 @default.
• W2024315099 hasConcept C118487528 @default.
• W2024315099 hasConcept C126322002 @default.
• W2024315099 hasConcept C134018914 @default.
• W2024315099 hasConcept C2776006263 @default.
• W2024315099 hasConcept C2778205975 @default.
• W2024315099 hasConcept C2778257484 @default.
• W2024315099 hasConcept C2778664715 @default.
• W2024315099 hasConcept C2779547634 @default.
• W2024315099 hasConcept C2779829184 @default.
• W2024315099 hasConcept C2780221984 @default.
• W2024315099 hasConcept C2781326671 @default.
• W2024315099 hasConcept C42219234 @default.
• W2024315099 hasConcept C44249647 @default.
• W2024315099 hasConcept C555293320 @default.
• W2024315099 hasConcept C68443243 @default.
• W2024315099 hasConcept C71924100 @default.
• W2024315099 hasConcept C84393581 @default.
• W2024315099 hasConceptScore W2024315099C118487528 @default.
• W2024315099 hasConceptScore W2024315099C126322002 @default.
• W2024315099 hasConceptScore W2024315099C134018914 @default.
• W2024315099 hasConceptScore W2024315099C2776006263 @default.
• W2024315099 hasConceptScore W2024315099C2778205975 @default.
• W2024315099 hasConceptScore W2024315099C2778257484 @default.
• W2024315099 hasConceptScore W2024315099C2778664715 @default.
• W2024315099 hasConceptScore W2024315099C2779547634 @default.
• W2024315099 hasConceptScore W2024315099C2779829184 @default.
• W2024315099 hasConceptScore W2024315099C2780221984 @default.
• W2024315099 hasConceptScore W2024315099C2781326671 @default.

• next